253 related articles for article (PubMed ID: 18593631)
1. HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study.
Pankow JS; Boerwinkle E; Adams PC; Guallar E; Leiendecker-Foster C; Rogowski J; Eckfeldt JH
Transl Res; 2008 Jul; 152(1):3-10. PubMed ID: 18593631
[TBL] [Abstract][Full Text] [Related]
2. Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
[TBL] [Abstract][Full Text] [Related]
3. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
[TBL] [Abstract][Full Text] [Related]
4. Significance of H63D homozygosity in a Basque population with hemochromatosis.
Castiella A; Zapata E; de Juan MD; Otazua P; Fernandez J; Zubiaurre L; Arriola JA;
J Gastroenterol Hepatol; 2010 Jul; 25(7):1295-8. PubMed ID: 20594259
[TBL] [Abstract][Full Text] [Related]
5. HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis.
Allen KJ; Bertalli NA; Osborne NJ; Constantine CC; Delatycki MB; Nisselle AE; Nicoll AJ; Gertig DM; McLaren CE; Giles GG; Hopper JL; Anderson GJ; Olynyk JK; Powell LW; Gurrin LC;
Hepatology; 2010 Sep; 52(3):925-33. PubMed ID: 20583211
[TBL] [Abstract][Full Text] [Related]
6. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV
J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997
[TBL] [Abstract][Full Text] [Related]
7. Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening.
McLaren GD; McLaren CE; Adams PC; Barton JC; Reboussin DM; Gordeuk VR; Acton RT; Harris EL; Speechley MR; Sholinsky P; Dawkins FW; Snively BM; Vogt TM; Eckfeldt JH;
Can J Gastroenterol; 2008 Nov; 22(11):923-30. PubMed ID: 19018338
[TBL] [Abstract][Full Text] [Related]
8. Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients.
Phatak PD; Ryan DH; Cappuccio J; Oakes D; Braggins C; Provenzano K; Eberly S; Sham RL
Blood Cells Mol Dis; 2002; 29(1):41-7. PubMed ID: 12482402
[TBL] [Abstract][Full Text] [Related]
10. Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.
Adams PC; Speechley M; Barton JC; McLaren CE; McLaren GD; Eckfeldt JH
Hepatology; 2012 Jun; 55(6):1722-6. PubMed ID: 22183642
[TBL] [Abstract][Full Text] [Related]
11. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study.
McLaren CE; Barton JC; Gordeuk VR; Wu L; Adams PC; Reboussin DM; Speechley M; Chang H; Acton RT; Harris EL; Ruggiero AM; Castro O;
Am J Hematol; 2007 Oct; 82(10):898-905. PubMed ID: 17597476
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study.
Rasmussen ML; Folsom AR; Catellier DJ; Tsai MY; Garg U; Eckfeldt JH
Atherosclerosis; 2001 Feb; 154(3):739-46. PubMed ID: 11257277
[TBL] [Abstract][Full Text] [Related]
13. Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study.
Zaloumis SG; Allen KJ; Bertalli NA; Turkovic L; Delatycki MB; Nicoll AJ; McLaren CE; English DR; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Gurrin LC;
J Gastroenterol Hepatol; 2015 Apr; 30(4):719-25. PubMed ID: 25311314
[TBL] [Abstract][Full Text] [Related]
14. Metabolic alterations, HFE gene mutations and atherogenic lipoprotein modifications in patients with primary iron overload.
Meroño T; Brites F; Dauteuille C; Lhomme M; Menafra M; Arteaga A; Castro M; Saez MS; Ballerga EG; Sorroche P; Rey J; Lesnik P; Sordá JA; Chapman MJ; Kontush A; Daruich J
Clin Sci (Lond); 2015 May; 128(9):609-18. PubMed ID: 25442240
[TBL] [Abstract][Full Text] [Related]
15. Genetic modifiers of penetrance to liver endpoints in HFE hemochromatosis: Associations in a large community cohort.
Pilling LC; Atkins JL; Melzer D
Hepatology; 2022 Dec; 76(6):1735-1745. PubMed ID: 35567766
[TBL] [Abstract][Full Text] [Related]
16. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism.
Njajou OT; Houwing-Duistermaat JJ; Osborne RH; Vaessen N; Vergeer J; Heeringa J; Pols HA; Hofman A; van Duijn CM
Eur J Hum Genet; 2003 Mar; 11(3):225-31. PubMed ID: 12673276
[TBL] [Abstract][Full Text] [Related]
17. HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.
Adams PC; McLaren CE; Speechley M; McLaren GD; Barton JC; Eckfeldt JH
Can J Gastroenterol; 2013 Jul; 27(7):390-2. PubMed ID: 23862168
[TBL] [Abstract][Full Text] [Related]
18. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
[TBL] [Abstract][Full Text] [Related]
19. Association of Hemochromatosis HFE p.C282Y Homozygosity With Hepatic Malignancy.
Atkins JL; Pilling LC; Masoli JAH; Kuo CL; Shearman JD; Adams PC; Melzer D
JAMA; 2020 Nov; 324(20):2048-2057. PubMed ID: 33231665
[TBL] [Abstract][Full Text] [Related]
20. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
